glp-1 and surgery risk Pulmonary Aspiration Warning for (Glucagon-like peptide-1) Diabetes Weight Loss Meds GLP-1 RA weight-loss drugs could

Downey, D

Engagement with Healthcare Providers: Recognizing the role of healthcare providers in patient safety, Novo Nordisk has worked to improve how information about Ozempics risks is communicated

GLP-1RA (such as exendin-4) treatment can reduce the size of MI impacted cardiac volume in rats, inhibit ventricular dilation, myocardial fibrosis and hypertrophy in vivo [72]

*In a clinical study by Ribeiro et al

[1] [2] Zepbound carries a boxed warning for thyroid C-cell tumors (observed in rodent studies) and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Over time, untreated OSA increases the risk of hypertension, heart disease, stroke, type 2 diabetes, and cognitive decline